Avtor/Urednik		Dernovšek, MZ; Tavčar, R
Naslov		Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone
Tip		članek
Vir		Int Clin Psychopharmacol
Vol. in št.		Letnik 15, št. 4
Leto izdaje		2000
Obseg		str. 237-8
Jezik		eng
Abstrakt		We report a 2-year experience with olanzapine treatment (20 mg daily) in a 65-year-old male patient with treatment-resistant paranoid schizophrenia, who had previously developed leucopenia and neutropenia first on clozapine and, subsequently, also on risperidone. Olanzapine seems to be safe in this patient, since no major decreases of haematological parameters were observed. The only exception was a brief decrease of leucocyte and neutrophil (but not erythrocyte or platelet) counts during influenza-like viral infection. However, the control of psychotic symptoms on olanzapine is not as good as on clozapine.
Deskriptorji		LEUKOPENIA PIRENZEPINE RISPERIDONE SCHIZOPHRENIA, PARANOID CLOZAPINE AGED DRUG MONITORING ANTIPSYCHOTIC AGENTS RISK FACTORS NEUTROPENIA